Logo image of SGMA

SIGMATRON INTERNATIONAL INC (SGMA) Stock Fundamental Analysis

USA - NASDAQ:SGMA - US82661L1017 - Common Stock

3.01 USD
-0.01 (-0.33%)
Last: 7/25/2025, 8:25:03 PM
3.01 USD
0 (0%)
After Hours: 7/18/2025, 8:11:59 PM
Fundamental Rating

2

SGMA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. SGMA has a bad profitability rating. Also its financial health evaluation is rather negative. SGMA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SGMA has reported negative net income.
SGMA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SGMA reported negative net income in multiple years.
In multiple years SGMA reported negative operating cash flow during the last 5 years.
SGMA Yearly Net Income VS EBIT VS OCF VS FCFSGMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

SGMA has a worse Return On Assets (-6.35%) than 60.80% of its industry peers.
SGMA's Return On Equity of -21.28% is on the low side compared to the rest of the industry. SGMA is outperformed by 66.40% of its industry peers.
Industry RankSector Rank
ROA -6.35%
ROE -21.28%
ROIC N/A
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)N/A
ROIC(5y)N/A
SGMA Yearly ROA, ROE, ROICSGMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of SGMA has grown nicely.
With a Gross Margin value of 7.42%, SGMA is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
SGMA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SGMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.42%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
SGMA Yearly Profit, Operating, Gross MarginsSGMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

3

2. Health

2.1 Basic Checks

SGMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SGMA has been increased compared to 1 year ago.
SGMA has more shares outstanding than it did 5 years ago.
SGMA has a better debt/assets ratio than last year.
SGMA Yearly Shares OutstandingSGMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGMA Yearly Total Debt VS Total AssetsSGMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.93 indicates that SGMA is not a great score, but indicates only limited risk for bankruptcy at the moment.
SGMA has a worse Altman-Z score (1.93) than 69.60% of its industry peers.
The Debt to FCF ratio of SGMA is 2.38, which is a good value as it means it would take SGMA, 2.38 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.38, SGMA is in the better half of the industry, outperforming 73.60% of the companies in the same industry.
SGMA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
SGMA's Debt to Equity ratio of 0.07 is in line compared to the rest of the industry. SGMA outperforms 56.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 2.38
Altman-Z 1.93
ROIC/WACCN/A
WACC10.81%
SGMA Yearly LT Debt VS Equity VS FCFSGMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

SGMA has a Current Ratio of 1.23. This is a normal value and indicates that SGMA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.23, SGMA is doing worse than 87.20% of the companies in the same industry.
SGMA has a Quick Ratio of 1.23. This is a bad value and indicates that SGMA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.35, SGMA is doing worse than 96.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.35
SGMA Yearly Current Assets VS Current LiabilitesSGMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1

3. Growth

3.1 Past

The earnings per share for SGMA have decreased strongly by -1202.52% in the last year.
SGMA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.02%.
SGMA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)-1202.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%539.22%
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-25.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGMA Yearly Revenue VS EstimatesSGMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

4. Valuation

4.1 Price/Earnings Ratio

SGMA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGMA Price Earnings VS Forward Price EarningsSGMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

SGMA's Enterprise Value to EBITDA ratio is in line with the industry average.
100.00% of the companies in the same industry are more expensive than SGMA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.78
EV/EBITDA 20.29
SGMA Per share dataSGMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SGMA!.
Industry RankSector Rank
Dividend Yield N/A

SIGMATRON INTERNATIONAL INC

NASDAQ:SGMA (7/25/2025, 8:25:03 PM)

After market: 3.01 0 (0%)

3.01

-0.01 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-06 2025-03-06
Earnings (Next)09-01 2025-09-01
Inst Owners37.75%
Inst Owner Change-3.72%
Ins Owners18.85%
Ins Owner Change-714.86%
Market Cap18.42M
Revenue(TTM)311.71M
Net Income(TTM)-12247800
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 0.78
P/OCF 0.75
P/B 0.32
P/tB 0.32
EV/EBITDA 20.29
EPS(TTM)-2.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.85
FCFY127.99%
OCF(TTM)4.03
OCFY133.74%
SpS50.93
BVpS9.4
TBVpS9.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.35%
ROE -21.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.42%
FCFM 7.56%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.02%
ROCE(5y)9.57%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
F-Score3
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 2.38
Debt/EBITDA 1.14
Cap/Depr 17.46%
Cap/Sales 0.34%
Interest Coverage N/A
Cash Conversion 690.28%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.35
Altman-Z 1.93
F-Score3
WACC10.81%
ROIC/WACCN/A
Cap/Depr(3y)59.02%
Cap/Depr(5y)70.3%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1202.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%539.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-25.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-109.88%
EBIT growth 3Y28.02%
EBIT growth 5Y18.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y150.38%
FCF growth 3Y97.89%
FCF growth 5YN/A
OCF growth 1Y153.86%
OCF growth 3Y50.77%
OCF growth 5YN/A

SIGMATRON INTERNATIONAL INC / SGMA FAQ

What is the ChartMill fundamental rating of SIGMATRON INTERNATIONAL INC (SGMA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SGMA.


Can you provide the valuation status for SIGMATRON INTERNATIONAL INC?

ChartMill assigns a valuation rating of 2 / 10 to SIGMATRON INTERNATIONAL INC (SGMA). This can be considered as Overvalued.


How profitable is SIGMATRON INTERNATIONAL INC (SGMA) stock?

SIGMATRON INTERNATIONAL INC (SGMA) has a profitability rating of 2 / 10.